A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast Cancer

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Breast Cancer (Locally Advanced or Metastatic) Sponsors: Jie Yuan，MD Recruiting Conditions: Breast Cancer (Locally Advanced or Metastatic) Sponsors: Jie Yuan，MD Recruiting 

Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Community-acquired Pneumonia; CAP; Community Acquired Pneumonia; Pneumonia; Microbial Composition Interventions: Drug: Inhaled levofloxacin; Drug: Standard-of-care / Usual care Sponsors: Copenhagen Respiratory Research Not yet recruiting Conditions:...

Green Banana Added Diet on Prolong Diarrhea in 6-59 Months Old Children (GB in ProD)

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Diarrhoeal Disease; Prolonged Diarrhea Interventions: Drug: MS; Drug: MS +GB Sponsors: International Centre for Diarrhoeal Disease Research, Bangladesh Not yet recruiting Conditions: Diarrhoeal Disease; Prolonged Diarrhea Interventions: Drug: MS; Drug:...

INtubation With Sedation Only to Preserve Independent Respiratory Effort Trial

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Acute Respiratory Failure Interventions: Other: Intubation with a sedative medication only; Other: Intubation with a sedative medication and neuromuscular blockade agent Sponsors: Vanderbilt University Medical Center; National Heart, Lung, and Blood...

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Advanced Gynecological Tumors.

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Advanced Gynecologic Malignancies Interventions: Drug: RNK08954 Sponsors: Ranok Therapuetics Co. Ltd. Not yet recruiting Conditions: Advanced Gynecologic Malignancies Interventions: Drug: RNK08954 Sponsors: Ranok Therapuetics Co. Ltd. Not yet...

REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants

by palligoelme@gmail.com | Sep 30, 2026 | Clinical Trials

​ Conditions: Metastatic Castration-Resistant Prostate Cancer; mCRPC Interventions: Drug: REGN21353; Drug: Nezastomig; Drug: Sarilumab Prophylaxis (Contingency) Sponsors: Regeneron Pharmaceuticals Not yet recruiting Conditions: Metastatic Castration-Resistant Prostate...